The integration of molecular docking techniques into the design and evaluation of novel antimicrobial agents has rapidly transformed drug discovery. This approach involves using advanced computational ...
After presenting comparable docking results last year—and using them to prospectively identify drug candidates on difficult targets—Deep Origin welcomes Isomorphic Labs to the frontier SOUTH SAN ...
Optibrium, a leading developer of software and AI solutions for molecular design today announced the publication of a peer-reviewed study in the Journal of Computer-Aided Molecular Design, ...
Epidermal growth factor receptor (EGFR) inhibitor-induced dermal toxicity treated with topical application of a novel Staphylococcus epidermidis compound. This is an ASCO Meeting Abstract from the ...
(a–c) The 3D visualization of molecular docking modes of HXTL’s top four active components (luteolin, beta-sitosterol, stigmasterol, quercetin) and top three HXTL-PMOP targets (IL6, AKT1, PI3K). (d) ...
Manas AI Inc., a startup using artificial intelligence to discover new medicines, launched today with $24.6 million in initial funding. The investment was led by General Catalyst and Manas AI ...
Ainnocence, a leader in next-generation AI drug-discovery solutions, today released a comprehensive white paper detailing persistent scientific obstacles that limit the accuracy and ROI of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results